• TB Infection Rates Could Turn the Clock Back to the 1930s
    Tuberculosis seems set on defying concerted efforts to treat it successfully with powerful drugs, turning the clock back to the 1930s, warn the editors of the journal Thorax in a special themed issue of the journal to mark World TB day on March 24, and published today. ...More
    February 12, 2013 Posted in News
  • A Novel Pathway for a Mucosal TB Vaccine
    A new pathway for improving vaccines against tuberculosis has been discovered by microbiologists at the University at Buffalo in collaboration with researchers at other universities, according to a paper in the journal Mucosal Immunology, published by the Nature group. Lead ...More
    February 1, 2013 Posted in News
  • Medicinal Toothbrush Tree Yields Antibiotic to Treat TB in New Way
    A compound from the South African toothbrush tree inactivates a drug target for tuberculosis in a previously unseen way. Tuberculosis causes more deaths worldwide than any other bacterial disease. At the same time as rates are increasing, resistance strains are emerging ...More
    January 14, 2013 Posted in News
  • Researchers Find Molecule That Polices TB Lung Infection
    The presence of a certain molecule allows the immune system to effectively police tuberculosis (TB) of the lungs and prevent it from turning into an active and deadly infection, according to a new study led by researchers at Children's Hospital of Pittsburgh of UPMC and the ...More
    January 3, 2013 Posted in News
  • FDA Approves First Drug to Treat Multidrug-Resistant Tuberculosis
    The Food and Drug Administration (FDA) has approved Sirturo (bedaquiline) as part of combination therapy to treat adults with multi-drug resistant pulmonary tuberculosis (TB) when other alternatives are not available. TB is an infection caused by Mycobacterium tuberculosis ...More
    January 1, 2013 Posted in News
  • Stroke Drug Kills Bacteria That Cause Ulcers and Tuberculosis
    A drug currently being used to treat ischemic strokes may prove to be a significant advance in the treatment of tuberculosis and ulcers. In a new research report appearing online in the FASEB Journal, a compound called ebselen effectively inhibits the thioredoxin reductase ...More
    December 25, 2012 Posted in News
  • UNITAID Grants Focus on Childhood HIV/AIDS, Malaria and Tuberculosis
    UNITAID announces it has made new grants to allow hundreds of thousands of children in developing countries to access better and more affordable medicines for HIV/AIDS, malaria and tuberculosis (TB). “For too long now, the global health community has done too little to meet ...More
    December 10, 2012 Posted in News
  • SLU's TB Vaccine Research Could Accelerate Life-Saving Discoveries
    A pilot study at Saint Louis University Center for Vaccine Development could shape the future of tuberculosis vaccine research by developing tests to identify the most promising vaccine candidates to address this global health crisis. ...More
    November 28, 2012 Posted in News
  • 'Repurposed' Anti-Parasite Drug Shows Promise as New TB Treatment
    A well-established family of drugs used to treat parasitic diseases is showing surprising potential as a therapy for tuberculosis (TB), according to new research from University of British Columbia microbiologists. The findings, published online this week in the journal ...More
    November 26, 2012 Posted in News
  • 'Missing Link' Discovered in the Defense Mechanism of the Tuberculosis Pathogen
    Flemish biologists led by Joris Messens of the Flanders Institute for Biotechnology have discovered that Mycobacterium tuberculosis – the bacterium that causes tuberculosis – has an ingenious defense mechanism against oxygen. This knowledge is important in the search for a ...More
    November 14, 2012 Posted in News